Global COVID-19 Inactivated Vaccine Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global COVID-19 Inactivated Vaccine Market Size 2022-2028

2.1.2 COVID-19 Inactivated Vaccine Market Size CAGR by Region

2.2 COVID-19 Inactivated Vaccine Segment by Type

2.2.1 In Clinical Trials

2.2.2 Out-of-Clinical Trials

2.3 COVID-19 Inactivated Vaccine Market Size by Type

2.3.1 Global COVID-19 Inactivated Vaccine Market Size Market Share by Type (2022-2028)

2.3.2 Global COVID-19 Inactivated Vaccine Market Size Growth Rate by Type (2022-2028)

2.4 COVID-19 Inactivated Vaccine Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Other

2.5 COVID-19 Inactivated Vaccine Market Size by Application

2.5.1 Global COVID-19 Inactivated Vaccine Market Size Market Share by Application (2022-2028)

2.5.2 Global COVID-19 Inactivated Vaccine Market Size Growth Rate by Application (2022-2028)

3 COVID-19 Inactivated Vaccine Key Players

3.1 Date of Key Players Enter into COVID-19 Inactivated Vaccine

3.2 Key Players COVID-19 Inactivated Vaccine Product Offered

3.3 Key Players COVID-19 Inactivated Vaccine Funding/Investment Analysis

3.4 Funding/Investment

3.4.1 Funding/Investment by Regions

3.4.2 Funding/Investment by End-Industry

3.5 Key Players COVID-19 Inactivated Vaccine Valuation & Market Capitalization

3.6 Key Players Mergers & Acquisitions, Expansion Plans

3.7 Market Ranking

3.8 New Product/Technology Launches

3.9 Partnerships, Agreements, and Collaborations

3.10 Mergers and Acquisitions

4 COVID-19 Inactivated Vaccine by Regions

4.1 COVID-19 Inactivated Vaccine Market Size by Regions (2022-2028)

4.2 United States COVID-19 Inactivated Vaccine Market Size Growth (2022-2028)

4.3 China COVID-19 Inactivated Vaccine Market Size Growth (2022-2028)

4.4 Europe COVID-19 Inactivated Vaccine Market Size Growth (2022-2028)

4.5 Rest of World COVID-19 Inactivated Vaccine Market Size Growth (2022-2028)

5 United States

5.1 United States COVID-19 Inactivated Vaccine Market Size by Type (2022-2028)

5.2 United States COVID-19 Inactivated Vaccine Market Size by Application (2022-2028)

6 China

6.1 China COVID-19 Inactivated Vaccine Market Size by Type (2022-2028)

6.2 China COVID-19 Inactivated Vaccine Market Size by Application (2022-2028)

7 Europe

7.1 Europe COVID-19 Inactivated Vaccine Market Size by Type (2022-2028)

7.2 Europe COVID-19 Inactivated Vaccine Market Size by Application (2022-2028)

8 Rest of World

8.1 Rest of World COVID-19 Inactivated Vaccine Market Size by Type (2022-2028)

8.2 Rest of World COVID-19 Inactivated Vaccine Market Size by Application (2022-2028)

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Key Investors in COVID-19 Inactivated Vaccine

10.1 Company A

10.1.1 Company A Company Details

10.1.2 Company Description

10.1.3 Companies Invested by Company A

10.1.4 Company A Key Development and Market Layout

10.2 Company B

10.2.1 Company B Company Details

10.2.2 Company Description

10.2.3 Companies Invested by Company B

10.2.4 Company B Key Development and Market Layout

10.3 Company C

10.3.1 Company C Company Details

10.3.2 Company Description

10.3.3 Companies Invested by Company C

10.3.4 Company C Key Development and Market Layout

10.4 Company D

10.5 ……

11 Key Players Analysis

11.1 Inovio Pharmaceuticals

11.1.1 Inovio Pharmaceuticals Company Details

11.1.2 Inovio Pharmaceuticals COVID-19 Inactivated Vaccine Product Offered

11.1.3 Inovio Pharmaceuticals COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

11.1.4 Inovio Pharmaceuticals Main Business Overview

11.1.5 Inovio Pharmaceuticals News

11.2 Takis Biotech (Evvivax)

11.2.1 Takis Biotech (Evvivax) Company Details

11.2.2 Takis Biotech (Evvivax) COVID-19 Inactivated Vaccine Product Offered

11.2.3 Takis Biotech (Evvivax) COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

11.2.4 Takis Biotech (Evvivax) Main Business Overview

11.2.5 Takis Biotech (Evvivax) News

11.3 Zydus Cadila

11.3.1 Zydus Cadila Company Details

11.3.2 Zydus Cadila COVID-19 Inactivated Vaccine Product Offered

11.3.3 Zydus Cadila COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

11.3.4 Zydus Cadila Main Business Overview

11.3.5 Zydus Cadila News

11.4 Codagenix, Inc.

11.4.1 Codagenix, Inc. Company Details

11.4.2 Codagenix, Inc. COVID-19 Inactivated Vaccine Product Offered

11.4.3 Codagenix, Inc. COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

11.4.4 Codagenix, Inc. Main Business Overview

11.4.5 Codagenix, Inc. News

11.5 GeoVax, Inc.

11.5.1 GeoVax, Inc. Company Details

11.5.2 GeoVax, Inc. COVID-19 Inactivated Vaccine Product Offered

11.5.3 GeoVax, Inc. COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

11.5.4 GeoVax, Inc. Main Business Overview

11.5.5 GeoVax, Inc. News

11.6 Bravovax

11.6.1 Bravovax Company Details

11.6.2 Bravovax COVID-19 Inactivated Vaccine Product Offered

11.6.3 Bravovax COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

11.6.4 Bravovax Main Business Overview

11.6.5 Bravovax News

11.7 Janssen Pharmaceutical Companies

11.7.1 Janssen Pharmaceutical Companies Company Details

11.7.2 Janssen Pharmaceutical Companies COVID-19 Inactivated Vaccine Product Offered

11.7.3 Janssen Pharmaceutical Companies COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

11.7.4 Janssen Pharmaceutical Companies Main Business Overview

11.7.5 Janssen Pharmaceutical Companies News

11.8 Altimmune

11.8.1 Altimmune Company Details

11.8.2 Altimmune COVID-19 Inactivated Vaccine Product Offered

11.8.3 Altimmune COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

11.8.4 Altimmune Main Business Overview

11.8.5 Altimmune News

11.9 Vaxart

11.9.1 Vaxart Company Details

11.9.2 Vaxart COVID-19 Inactivated Vaccine Product Offered

11.9.3 Vaxart COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

11.9.4 Vaxart Main Business Overview

11.9.5 Vaxart News

11.10 CanSino Biologics

11.10.1 CanSino Biologics Company Details

11.10.2 CanSino Biologics COVID-19 Inactivated Vaccine Product Offered

11.10.3 CanSino Biologics COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

11.10.4 CanSino Biologics Main Business Overview

11.10.5 CanSino Biologics News

11.11 ExpreS2ion Biotechnologies ApS

11.12 Clover Biopharmaceuticals

11.13 GSK

11.14 Vaxil Bio Ltd.

11.15 Generex

11.16 Novavax, Inc.

11.17 Sanofi Pasteur

11.18 Baylor

11.19 iBio, Inc.

11.20 Moderna, Inc.

11.21 Curevac

11.22 ImmunoPrecise

12 Research Findings and Conclusion

Table 1. COVID-19 Inactivated Vaccine Market Size CAGR by Region (2022-2028) ($ Millions)

Table 2. Major Players of In Clinical Trials

Table 3. Major Players of Out-of-Clinical Trials

Table 4. Global COVID-19 Inactivated Vaccine Market Size by Type (2022-2028) ($ Millions)

Table 5. Global COVID-19 Inactivated Vaccine Market Size Market Share by Type (2022-2028)

Table 6. Global COVID-19 Inactivated Vaccine Market Size by Application (2022-2028) ($ Millions)

Table 7. Global COVID-19 Inactivated Vaccine Market Size Market Share by Application (2022-2028)

Table 8. Date of Global Key Players Enter into COVID-19 Inactivated Vaccine Market

Table 9. Global Key Players COVID-19 Inactivated Vaccine Product Offered

Table 10. Key Players COVID-19 Inactivated Vaccine Funding/Investment ($ Millions)

Table 11. Funding/Investment by Regions

Table 12. Funding/Investment by End Industry

Table 13. Key Players COVID-19 Inactivated Vaccine Valuation & Market Capitalization ($ Millions)

Table 14. Key Players Mergers & Acquisitions, Expansion Plans

Table 15. COVID-19 Inactivated Vaccine New Product/Technology Launches

Table 16. COVID-19 Inactivated Vaccine Industry Partnerships, Agreements, and Collaborations

Table 17. COVID-19 Inactivated Vaccine Industry Mergers and Acquisitions

Table 18. Global COVID-19 Inactivated Vaccine Market Size by Regions 2022-2028 ($ Millions)

Table 19. Global COVID-19 Inactivated Vaccine Market Size Market Share by Regions 2022-2028

Table 20. United States COVID-19 Inactivated Vaccine Market Size by Type (2022-2028) ($ Millions)

Table 21. United States COVID-19 Inactivated Vaccine Market Size Market Share by Type (2022-2028)

Table 22. United States COVID-19 Inactivated Vaccine Market Size by Application (2022-2028) ($ Millions)

Table 23. United States COVID-19 Inactivated Vaccine Market Size Market Share by Application (2022-2028)

Table 24. China COVID-19 Inactivated Vaccine Market Size by Type (2022-2028) ($ Millions)

Table 25. China COVID-19 Inactivated Vaccine Market Size Market Share by Type (2022-2028)

Table 26. China COVID-19 Inactivated Vaccine Market Size by Application (2022-2028) ($ Millions)

Table 27. China COVID-19 Inactivated Vaccine Market Size Market Share by Application (2022-2028)

Table 28. Europe COVID-19 Inactivated Vaccine Market Size by Type (2022-2028) ($ Millions)

Table 29. Europe COVID-19 Inactivated Vaccine Market Size Market Share by Type (2022-2028)

Table 30. Europe COVID-19 Inactivated Vaccine Market Size by Application (2022-2028) ($ Millions)

Table 31. Europe COVID-19 Inactivated Vaccine Market Size Market Share by Application (2022-2028)

Table 32. Rest of World COVID-19 Inactivated Vaccine Market Size by Type (2022-2028) ($ Millions)

Table 33. Rest of World COVID-19 Inactivated Vaccine Market Size Market Share by Type (2022-2028)

Table 34. Rest of World COVID-19 Inactivated Vaccine Market Size by Application (2022-2028) ($ Millions)

Table 35. Rest of World COVID-19 Inactivated Vaccine Market Size Market Share by Application (2022-2028)

Table 36. Key Market Drivers & Growth Opportunities of COVID-19 Inactivated Vaccine

Table 37. Key Market Challenges & Risks of COVID-19 Inactivated Vaccine

Table 38. Key Industry Trends of COVID-19 Inactivated Vaccine

Table 39. Company A Company Details

Table 40. Companies Invested by Company A

Table 41. Company A Key Development and Market Layout

Table 42. Company B Company Details

Table 43. Companies Invested by Company B

Table 44. Company B Key Development and Market Layout

Table 45. Company C Company Details

Table 46. Companies Invested by Company C

Table 47. Company C Key Development and Market Layout

Table 48. Company C Company Details

Table 49. Companies Invested by Company C

Table 50. Company C Key Development and Market Layout

Table 51. Inovio Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors

Table 52. Inovio Pharmaceuticals COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

Table 53. Takis Biotech (Evvivax) Basic Information, Head Office, Major Market Areas and Its Competitors

Table 54. Takis Biotech (Evvivax) COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

Table 55. Zydus Cadila Basic Information, Head Office, Major Market Areas and Its Competitors

Table 56. Zydus Cadila COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

Table 57. Codagenix, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 58. Codagenix, Inc. COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

Table 59. GeoVax, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 60. GeoVax, Inc. COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

Table 61. Bravovax Basic Information, Head Office, Major Market Areas and Its Competitors

Table 62. Bravovax COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

Table 63. Janssen Pharmaceutical Companies Basic Information, Head Office, Major Market Areas and Its Competitors

Table 64. Janssen Pharmaceutical Companies COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

Table 65. Altimmune Basic Information, Head Office, Major Market Areas and Its Competitors

Table 66. Altimmune COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

Table 67. Vaxart Basic Information, Head Office, Major Market Areas and Its Competitors

Table 68. Vaxart COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

Table 69. CanSino Biologics Basic Information, Head Office, Major Market Areas and Its Competitors

Table 70. CanSino Biologics COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

Table 71. ExpreS2ion Biotechnologies ApS Basic Information, Head Office, Major Market Areas and Its Competitors

Table 72. ExpreS2ion Biotechnologies ApS COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

Table 73. Clover Biopharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors

Table 74. Clover Biopharmaceuticals COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

Table 75. GSK Basic Information, Head Office, Major Market Areas and Its Competitors

Table 76. GSK COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

Table 77. Vaxil Bio Ltd. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 78. Vaxil Bio Ltd. COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

Table 79. Generex Basic Information, Head Office, Major Market Areas and Its Competitors

Table 80. Generex COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

Table 81. Novavax, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 82. Novavax, Inc. COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

Table 83. Sanofi Pasteur Basic Information, Head Office, Major Market Areas and Its Competitors

Table 84. Sanofi Pasteur COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

Table 85. Baylor Basic Information, Head Office, Major Market Areas and Its Competitors

Table 86. Baylor COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

Table 87. iBio, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 88. iBio, Inc. COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

Table 89. Moderna, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 90. Moderna, Inc. COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

Table 91. Curevac Basic Information, Head Office, Major Market Areas and Its Competitors

Table 92. Curevac COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

Table 93. ImmunoPrecise Basic Information, Head Office, Major Market Areas and Its Competitors

Table 94. ImmunoPrecise COVID-19 Inactivated Vaccine Market Size (2022 VS 2027)

List of Figures

Figure 1. Picture of COVID-19 Inactivated Vaccine

Figure 2. COVID-19 Inactivated Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global COVID-19 Inactivated Vaccine Market Size Growth Rate 2022-2028 ($ Millions)

Figure 7. COVID-19 Inactivated Vaccine Market Size by Region (2022 & 2027) ($ millions)

Figure 8. Global COVID-19 Inactivated Vaccine Market Size Market Share by Type (2022-2028)

Figure 9. Global In Clinical Trials Market Size Growth Rate

Figure 10. Global Out-of-Clinical Trials Market Size Growth Rate

Figure 11. COVID-19 Inactivated Vaccine in Hospital

Figure 12. Global COVID-19 Inactivated Vaccine Market: Hospital (2022-2028) ($ Millions)

Figure 13. COVID-19 Inactivated Vaccine in Clinic

Figure 14. Global COVID-19 Inactivated Vaccine Market: Clinic (2022-2028) ($ Millions)

Figure 15. COVID-19 Inactivated Vaccine in Other

Figure 16. Global COVID-19 Inactivated Vaccine Market: Other (2022-2028) ($ Millions)

Figure 17. Global COVID-19 Inactivated Vaccine Market Size Market Share by Application (2022-2028)

Figure 18. Global COVID-19 Inactivated Vaccine Market Size in Hospital Growth Rate

Figure 19. Global COVID-19 Inactivated Vaccine Market Size in Clinic Growth Rate

Figure 20. Global COVID-19 Inactivated Vaccine Market Size in Other Growth Rate

Figure 21. Funding/Investment

Figure 22. Global COVID-19 Inactivated Vaccine Market Size Market Share by Regions 2022-2028

Figure 23. United States COVID-19 Inactivated Vaccine Market Size 2022-2028 ($ Millions)

Figure 24. China COVID-19 Inactivated Vaccine Market Size 2022-2028 ($ Millions)

Figure 25. Europe COVID-19 Inactivated Vaccine Market Size 2022-2028 ($ Millions)

Figure 26. Rest of World COVID-19 Inactivated Vaccine Market Size 2022-2028 ($ Millions)

Figure 27. United States COVID-19 Inactivated Vaccine Consumption Market Share by Type in 2027

Figure 28. United States COVID-19 Inactivated Vaccine Market Size Market Share by Application in 2027

Figure 29. China COVID-19 Inactivated Vaccine Consumption Market Share by Type in 2027

Figure 30. China COVID-19 Inactivated Vaccine Market Size Market Share by Application in 2027

Figure 31. Europe COVID-19 Inactivated Vaccine Consumption Market Share by Type in 2027

Figure 32. Europe COVID-19 Inactivated Vaccine Market Size Market Share by Application in 2027

Figure 33. Rest of World COVID-19 Inactivated Vaccine Consumption Market Share by Type in 2027

Figure 34. Rest of World COVID-19 Inactivated Vaccine Market Size Market Share by Application in 2027